Ipamorelin vs Sermorelin: Results Timeline Most patients do not see results overnight
It can be given via IV add on or injection
Finally, the important but less common outcome of nonfatal stroke was reduced with GLP-1RA, particularly in the Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes (SUSTAIN) 6 trial (semaglutide once weekly injection) and Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND
Ethics declarations Competing interests J.M.J., J.F.H., I.B., J.M.M., B.H., K.P., J.J.F., S.S., A.S., S.L., K.R
Ideal candidates might include those who: Have documented binge eating episodes causing significant distress Meet BMI criteria for weight management medications Have not responded adequately to psychological interventions (such as cognitive behavioural therapy) Do not have contraindications to GLP-1 therapy Understand the off-label nature of this indication UK SmPCs for GLP-1 medications note findings of thyroid C-cell tumours in rodent studies, though the relevance to humans remains uncertain
However, coverage for GLP-1 medications used to treat diabetes will continue